-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Nuvectis Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2021 to Q3 2025.
- Nuvectis Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$7.46M, a 79.7% decline year-over-year.
- Nuvectis Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$25.4M, a 31% decline year-over-year.
- Nuvectis Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$19M, a 14.6% increase from 2023.
- Nuvectis Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$22.3M, a 16.6% decline from 2022.
- Nuvectis Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.1M, a 48.1% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)